A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis [PDF]
Surgical Case Reports, 2023 Background CA15-3 is often elevated in breast cancer recurrence and rarely in ductal carcinoma in situ (DCIS). We report a case of DCIS with elevated CA15-3 levels, which was diagnosed after over 2 years of follow-up.
Mutsumi Fujimoto +4 more
doaj +2 more sources
Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients [PDF]
Scientific Reports, 2021 The purpose of this study is to evaluate the levels and clinical diagnosis value of CA15-3, CEA, and SF in canine mammary gland tumors (CMGTs). In this study, the levels of tissues/serum CA15-3, CEA, and SF in 178 CMGT patients or healthy dogs were ...
Yuying Fan +6 more
doaj +2 more sources
Electrochemical Immunosensor Based on CS@AuNPs/ZIF-8/rGO Composite for Detecting CA15-3 in Human Serum [PDF]
SensorsAn electrochemical immunosensor was fabricated to identify CA15-3, a biomarker for breast cancer (BC). A composite sensor substrate made of “zeolitic imidazolate framework-8” (ZIF-8) and “reduced graphene oxide” (rGO) was chosen and its conductivity was ...
Yuanyue Lu +8 more
doaj +2 more sources
Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma. [PDF]
PLoS ONE, 2019 Cancer antigen 15-3 (CA15-3) is widely utilized for monitoring metastatic breast cancer (BC). However, its utility for early detection of breast cancer is severely limited due to poor clinical sensitivity and specificity.
Joonas Terävä +5 more
doaj +2 more sources
An evaluation model of chemotherapy efficacy in breast cancer based on combined serum CA15-3, CEA, and CYFRA 21 − 1 [PDF]
BMC CancerBackground and aim Breast cancer remains one of the most prevalent malignancies in women worldwide, and chemotherapy plays a crucial role in systemic treatment.
Junya Zhang +4 more
doaj +2 more sources
Journal of Pharmacy and Bioallied SciencesBreast carcinoma is one of the leading causes of cancer-related mortality among women. Breast cancer survival is highly reliant on the stage of the disease at the time of diagnosis.
Dattu Hawale +2 more
doaj +3 more sources
Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis? [PDF]
International Journal of Women's Health, 2018 Lakmini KB Mudduwa,1 Gaya B Wijayaratne,2 Harshini H Peiris,3 Shania N Gunasekera,1 Deepthika Abeysiriwardhana,1 Nimsha Liyanage1 1Department of Pathology, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka; 2Department of Microbiology, Faculty
Mudduwa LKB +5 more
doaj +2 more sources
Comparison of BRCA1 Gene Expression and CA15-3 Tumor Marker Level in Different Stages of Breast Cancer [PDF]
The Breast JournalBreast cancer (BC), a globally prevalent malignancy, shows significant variability in incidence across different geographical regions. In this study, we examined the expression of the tumor suppressor gene BRCA1 and the tumor marker CA15-3 in women ...
Negar Soltani Irdmusa +4 more
doaj +2 more sources
Reliability of CA15-3 Tumor Marker in Monitoring Therapeutic Response in Different Molecular Subtypes of Metastatic Breast Cancer [PDF]
Middle East Journal of Cancer, 2022 Background: The prognostic impact of CA15-3 level in different molecular subtypes of metastatic breast cancer is not well elucidated yet; therefore, we conducted the present study to determine the reliability of CA15-3 tumor marker in terms of monitoring
Alya Al Zobair +2 more
doaj +1 more source
Journal of Techniques, 2022 Cancer antigen15-3 (CA15-3) is utilized as a tumor marker in breast cancer. In the metastatic situation, it has been regarded as having a predictive role.
Braihan Hamdi Hameed +2 more
doaj +1 more source